Implantable islet cells could control diabetes without insulin injections
The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.
Koch Institute
Study reveals why some cancer therapies don’t work for all patients
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
3 Questions: Building predictive models to characterize tumor progression
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
New AI model could cut the costs of developing protein drugs
MIT researchers used a large language model to optimize the genetic sequences of proteins manufactured by yeast, making production more efficient.
Richard Hynes, a pioneer in the biology of cellular adhesion, dies at 81
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.
Michael Moody: Impacting MIT through leadership in auditing
The Institute auditor has guided the Audit Division through a transformative period while strengthening collaborations across MIT.
Celebrating worm science
Time and again, an unassuming roundworm has illuminated aspects of biology with major consequences for human health.
AI-generated sensors open new paths for early cancer detection
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Study: High-fat diets make liver cells more likely to become cancerous
New research suggests liver cells exposed to too much fat revert to an immature state that is more susceptible to cancer-causing mutations.
A new immunotherapy approach could work for many types of cancer
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
MIT HEALS leadership charts a bold path for convergence in health and life sciences
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
School of Science welcomed new faculty in 2024
Eleven new professors join the departments of Biology; Brain and Cognitive Sciences; Earth, Atmospheric and Planetary Sciences; Mathematics; and Physics.
MIT researchers find new immunotherapeutic targets for glioblastoma
A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.